vs

Side-by-side financial comparison of OCULAR THERAPEUTIX, INC (OCUL) and TANDY LEATHER FACTORY INC (TLF). Click either name above to swap in a different company.

TANDY LEATHER FACTORY INC is the larger business by last-quarter revenue ($22.3M vs $13.3M, roughly 1.7× OCULAR THERAPEUTIX, INC). TANDY LEATHER FACTORY INC runs the higher net margin — -4.2% vs -488.0%, a 483.8% gap on every dollar of revenue. On growth, TANDY LEATHER FACTORY INC posted the faster year-over-year revenue change (8.7% vs -22.4%). TANDY LEATHER FACTORY INC produced more free cash flow last quarter ($4.0M vs $-57.1M). Over the past eight quarters, TANDY LEATHER FACTORY INC's revenue compounded faster (7.4% CAGR vs -5.3%).

Ocular Therapeutix, Inc. is a biopharmaceutical firm specializing in developing and commercializing innovative ophthalmic therapies. Its products treat acute and chronic eye conditions including post-surgical pain, glaucoma, and dry eye, serving patients and ophthalmology providers primarily across the U.S. and select global markets.

Tandy Leather Factory, Inc. is an American specialty retailer and wholesale distributor of leather and leatherwork related products. It operates more than 100 stores worldwide. Originally part of the Tandy Corporation, Tandy Leather has gone through a series of acquisitions and mergers, eventually being sold to The Leather Factory in 2000. The Tandy Leather flagship store next to their corporate headquarters in Fort Worth, Texas also houses the Al and Ann Stohlman Leathercraft Museum.

OCUL vs TLF — Head-to-Head

Bigger by revenue
TLF
TLF
1.7× larger
TLF
$22.3M
$13.3M
OCUL
Growing faster (revenue YoY)
TLF
TLF
+31.1% gap
TLF
8.7%
-22.4%
OCUL
Higher net margin
TLF
TLF
483.8% more per $
TLF
-4.2%
-488.0%
OCUL
More free cash flow
TLF
TLF
$61.1M more FCF
TLF
$4.0M
$-57.1M
OCUL
Faster 2-yr revenue CAGR
TLF
TLF
Annualised
TLF
7.4%
-5.3%
OCUL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
OCUL
OCUL
TLF
TLF
Revenue
$13.3M
$22.3M
Net Profit
$-64.7M
$-930.0K
Gross Margin
88.0%
54.3%
Operating Margin
-526.5%
-2.8%
Net Margin
-488.0%
-4.2%
Revenue YoY
-22.4%
8.7%
Net Profit YoY
-33.6%
-379.3%
EPS (diluted)
$-0.27
$-0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OCUL
OCUL
TLF
TLF
Q4 25
$13.3M
$22.3M
Q3 25
$14.5M
$17.3M
Q2 25
$13.5M
$17.8M
Q1 25
$10.7M
$19.0M
Q4 24
$17.1M
$20.5M
Q3 24
$15.4M
$17.4M
Q2 24
$16.4M
$17.3M
Q1 24
$14.8M
$19.3M
Net Profit
OCUL
OCUL
TLF
TLF
Q4 25
$-64.7M
$-930.0K
Q3 25
$-69.4M
$-1.4M
Q2 25
$-67.8M
$-199.0K
Q1 25
$-64.1M
$11.6M
Q4 24
$-48.4M
$333.0K
Q3 24
$-36.5M
$-132.0K
Q2 24
$-43.8M
$101.0K
Q1 24
$-64.8M
$525.0K
Gross Margin
OCUL
OCUL
TLF
TLF
Q4 25
88.0%
54.3%
Q3 25
87.8%
58.9%
Q2 25
85.6%
59.5%
Q1 25
88.2%
56.3%
Q4 24
92.8%
53.0%
Q3 24
89.9%
57.8%
Q2 24
90.8%
58.0%
Q1 24
91.0%
56.7%
Operating Margin
OCUL
OCUL
TLF
TLF
Q4 25
-526.5%
-2.8%
Q3 25
-472.3%
-3.9%
Q2 25
-502.6%
0.4%
Q1 25
-597.5%
1.4%
Q4 24
-296.1%
0.9%
Q3 24
-298.2%
-1.5%
Q2 24
-265.1%
0.4%
Q1 24
-214.0%
3.4%
Net Margin
OCUL
OCUL
TLF
TLF
Q4 25
-488.0%
-4.2%
Q3 25
-477.3%
-7.8%
Q2 25
-503.9%
-1.1%
Q1 25
-598.7%
60.8%
Q4 24
-283.3%
1.6%
Q3 24
-236.6%
-0.8%
Q2 24
-266.3%
0.6%
Q1 24
-438.9%
2.7%
EPS (diluted)
OCUL
OCUL
TLF
TLF
Q4 25
$-0.27
$-0.18
Q3 25
$-0.38
$-0.17
Q2 25
$-0.39
$-0.02
Q1 25
$-0.38
$1.47
Q4 24
$-0.25
$0.04
Q3 24
$-0.22
$-0.02
Q2 24
$-0.26
$0.01
Q1 24
$-0.49
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OCUL
OCUL
TLF
TLF
Cash + ST InvestmentsLiquidity on hand
$737.1M
$16.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$654.3M
$52.6M
Total Assets
$808.1M
$86.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OCUL
OCUL
TLF
TLF
Q4 25
$737.1M
$16.1M
Q3 25
$344.8M
$12.0M
Q2 25
$391.1M
$16.4M
Q1 25
$349.7M
$23.6M
Q4 24
$392.1M
$13.3M
Q3 24
$427.2M
$10.1M
Q2 24
$459.7M
$11.5M
Q1 24
$482.9M
$12.3M
Stockholders' Equity
OCUL
OCUL
TLF
TLF
Q4 25
$654.3M
$52.6M
Q3 25
$258.2M
$53.4M
Q2 25
$305.9M
$56.1M
Q1 25
$265.9M
$55.8M
Q4 24
$315.3M
$57.2M
Q3 24
$352.0M
$57.6M
Q2 24
$377.7M
$57.5M
Q1 24
$408.0M
$57.2M
Total Assets
OCUL
OCUL
TLF
TLF
Q4 25
$808.1M
$86.6M
Q3 25
$410.9M
$84.5M
Q2 25
$451.3M
$76.5M
Q1 25
$405.9M
$77.9M
Q4 24
$457.9M
$74.9M
Q3 24
$490.4M
$73.0M
Q2 24
$517.1M
$72.8M
Q1 24
$538.9M
$72.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OCUL
OCUL
TLF
TLF
Operating Cash FlowLast quarter
$-54.2M
$5.0M
Free Cash FlowOCF − Capex
$-57.1M
$4.0M
FCF MarginFCF / Revenue
-430.9%
18.1%
Capex IntensityCapex / Revenue
21.4%
4.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-216.9M
$-8.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OCUL
OCUL
TLF
TLF
Q4 25
$-54.2M
$5.0M
Q3 25
$-50.7M
$-1.0M
Q2 25
$-55.2M
$-4.0M
Q1 25
$-44.7M
$-536.0K
Q4 24
$-39.4M
$4.5M
Q3 24
$-36.6M
$-535.0K
Q2 24
$-24.8M
$-514.0K
Q1 24
$-33.9M
$1.1M
Free Cash Flow
OCUL
OCUL
TLF
TLF
Q4 25
$-57.1M
$4.0M
Q3 25
$-56.7M
$-3.0M
Q2 25
$-56.5M
$-7.3M
Q1 25
$-46.6M
$-1.9M
Q4 24
$-39.6M
$3.8M
Q3 24
$-36.6M
$-1.4M
Q2 24
$-25.5M
$-715.0K
Q1 24
$-34.1M
$-141.0K
FCF Margin
OCUL
OCUL
TLF
TLF
Q4 25
-430.9%
18.1%
Q3 25
-390.0%
-17.2%
Q2 25
-419.7%
-41.0%
Q1 25
-435.6%
-9.8%
Q4 24
-232.0%
18.8%
Q3 24
-237.6%
-8.2%
Q2 24
-155.4%
-4.1%
Q1 24
-231.1%
-0.7%
Capex Intensity
OCUL
OCUL
TLF
TLF
Q4 25
21.4%
4.3%
Q3 25
41.2%
11.2%
Q2 25
9.3%
18.7%
Q1 25
18.1%
7.0%
Q4 24
1.2%
3.3%
Q3 24
0.6%
5.1%
Q2 24
4.5%
1.2%
Q1 24
1.7%
6.4%
Cash Conversion
OCUL
OCUL
TLF
TLF
Q4 25
Q3 25
Q2 25
Q1 25
-0.05×
Q4 24
13.55×
Q3 24
Q2 24
-5.09×
Q1 24
2.07×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons